Skip to main content
. 2023 Sep 27;15(19):4750. doi: 10.3390/cancers15194750

Figure 1.

Figure 1

Figure 1

Figure 1

Different survivals at 2 and 5 years for the entire series. (a) Cancer-specific survival. (b) Disease-free survival. (c) Local (uterine) relapse-free survival. (d) Lymph node relapse (LRR)-free survival. (e) Distant metastasis-free survival.